Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Stryker Boosts Revenue Outlook as Surgeries Resume to Pre-Pandemic Extent

Stryker Boosts Revenue Outlook as Surgeries Resume to Pre-Pandemic Extent

7th August 2023

Due to surgical setbacks, the business forecasts increased treatment demand to persist beyond 2024.

Stryker increased its earnings and income prediction for 2023, highlighting higher procedure quantities, enhanced component availability, and the impact of Stryker’s implemented price strategies

Stryker’s Chairman of Corporate Relations Jason Beach stated. “In most countries, procedural volumes have largely recovered to pre-COVID levels.” And, while volumes are robust, there is still a patient backlog, and we expect the heightened orthopedic procedure demand will continue well into 2024.”

Stryker recorded an increase of 12% in revenue in neuroscience segments and a 10% increase in osteopathy and spine sectors. According to CEO Kevin Lobo, new products will aid the business maintain its present rate of growth.

He reiterated, “We think we have a winning hand, and we’re going to continue to play that hand,”

© Copyright 2010-2021 Zenopa LTD. All Rights Reserved.

We currently have 7 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.